|
Market Closed -
Bombay S.E.
03:32:24 04/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2,958.60 INR | +0.79% |
|
-4.75% | +19.74% |
| 03/08 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 03/08 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 530.85Cr | - | - | |||
| 1,02400Cr | |||||
| 66TCr | - | - | - | ||
| 45TCr | |||||
| 35TCr | |||||
| 30TCr |
Select your edition
All financial news and data tailored to specific country editions
